Folgen
Nathan Kipniss
Nathan Kipniss
Scientist
Bestätigte E-Mail-Adresse bei alum.mit.edu
Titel
Zitiert von
Zitiert von
Jahr
CRISPR-mediated programmable 3D genome positioning and nuclear organization
H Wang, X Xu, CM Nguyen, Y Liu, Y Gao, X Lin, T Daley, NH Kipniss, ...
Cell 175 (5), 1405-1417. e14, 2018
2092018
Genetically engineering self-organization of human pluripotent stem cells into a liver bud-like tissue using Gata6
P Guye, MR Ebrahimkhani, N Kipniss, JJ Velazquez, E Schoenfeld, ...
Nature communications 7 (1), 10243, 2016
1752016
Anti-CRISPR-mediated control of gene editing and synthetic circuits in eukaryotic cells
M Nakamura, P Srinivasan, M Chavez, MA Carter, AA Dominguez, ...
Nature communications 10 (1), 194, 2019
1592019
Engineering cell sensing and responses using a GPCR-coupled CRISPR-Cas system
NH Kipniss, PCDP Dingal, TR Abbott, Y Gao, H Wang, AA Dominguez, ...
Nature communications 8 (1), 2212, 2017
1112017
The CRISPR Revolution: What Editing Human DNA Reveals About the Patent System's DNA
R Feldman
UCLA L. Rev. Discourse 64, 392, 2016
72016
Anti-CRISPR-mediated control of gene editing and synthetic circuits in eukaryotic cells. Nat Commun 10: 194
M Nakamura, P Srinivasan, M Chavez, MA Carter, AA Dominguez, ...
62019
Genetically engineering self-organization of human pluripotent stem cells into a liver bud-like tissue using Gata6. Nat Commun 7: 10243
P Guye, MR Ebrahimkhani, N Kipniss, JJ Velazquez, E Schoenfeld, ...
doi. org/10.1038/ncomm s1024 3, 2016
52016
Bivalent chimeric engulfment receptors and uses thereof
DM Corey, N Kipniss
US Patent App. 17/154,959, 2021
22021
Engineering Cell Sensing and Responses Using a GPCR-Coupled CRISPR-Cas System
PCDP Dingal, NH Kipniss, L Labanieh, Y Gao, LS Qi
bioRxiv, 152496, 2017
12017
Engineering in vitro human hepatic organoids: 103
MR Ebrahimkhani, P Guye, N Kipniss, J Velazquez, R Weiss, L Griffith
Hepatology 60, 249A-250A, 2014
12014
Anti-cd72 chimeric receptors and uses thereof
DM Corey, N Kipniss, Y Koide, B Cieniewicz, Y Qu, S Thomas
US Patent App. 18/418,120, 2024
2024
Chimeric tim receptors and uses thereof
DM Corey, N Kipniss
US Patent App. 18/041,195, 2024
2024
Efficient and Specific In Vivo Genetic Engineering of Human Hematopoietic Stem Progenitor Cells without Selective Conditioning
VV Botchkarev Jr, S Harrington, A Justen, C Kimber, A Kapuria, Y Xu, ...
Blood 142, 2252, 2023
2023
Abstract B075: Conversion of extracellular signals to programmable genome manipulation via CRISPRouter
PCDP Dingal, N Kipniss, Y Gao, LS Qi
Cancer Immunology Research 4 (11_Supplement), B075-B075, 2016
2016
Micro RNA 21 inhibition of SMAD 7 enhances fibrogen-esis via leptin mediated NADPH oxidase in experimen-tal nonalcoholic steatohepatitis
MR Ebrahimkhani, P Guye, N Kipniss, J Velazquez, R Weiss, L Griffith
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–15